BIOLASE to Participate at Dougherty & Company Institutional Investor Conference on September 5, 2019

Wednesday, August 28, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

IRVINE, Calif., Aug. 28, 2019 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has been invited to participate at the 4th Annual Dougherty & Company Institutional Investor Conference being held September 5, 2019 at the Millennium Hotel in Minneapolis, MN.

President

and CEO Todd Norbe and Executive Vice President and CFO John Beaver will hold one-on-one and small group meetings with institutional investors throughout the day.

For additional information or to schedule a one-on-one meeting with BIOLASE, please contact your Dougherty representative.

About BIOLASE

BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and surgical applications. BIOLASE's laser systems are designed to provide clinically superior, patient-friendly results for many types of common dental procedures compared to those achieved with traditional instruments. BIOLASE has sold 38,900 laser systems to date in over 90 countries around the world.

For updates and information on Waterlase iPlus®, Waterlase Express™, and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, LinkedIn at www.linkedin.com/company/biolase, Instagram at www.instagram.com/waterlase_laserdentistry, and YouTube at www.youtube.com/biolasevideos.

BIOLASE®, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE, Inc.

Cision View original content:http://www.prnewswire.com/news-releases/biolase-to-participate-at-dougherty--company-institutional-investor-conference-on-september-5-2019-300908143.html

SOURCE BIOLASE, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store